A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Clinical trial NCT03472560 · TERMINATED
Trial details
- NCT number
- NCT03472560
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2023-02-09
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.